Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening
Abstract Background Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus (hrHPV) types is more effective than cytology-based screening. This study completes the diagnostic accuracy assessment conducted previously within the framework of VALGENT-2 (Validation of HPV g...
Main Authors: | Ajmal Akbari, Davy Vanden Broeck, Ina Benoy, Elizaveta Padalko, Johannes Bogers, Marc Arbyn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12985-018-1076-6 |
Similar Items
-
Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
by: Lan Xu, et al.
Published: (2018-09-01) -
Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
by: Birgit Engesæter, et al.
Published: (2016-11-01) -
Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
by: Hélène De Pauw, et al.
Published: (2021-08-01) -
HPV knowledge of college females and their intention to receive the HPV vaccination
by: Smith, Lisa G.
Published: (2011) -
Prophylactic HPV vaccines
by: Mandić Aljoša
Published: (2009-01-01)